Obagi Medical Products Inc. (Nasdaq: OMPI) has gotten another offer – this time from Merz Pharma Group for about $383.5 million.

The purchase price works out to $22 per share in cash.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.